Table 1

HLA type of patients enrolled in study

HLA-A, -B, and -DR were determined on aliquots of PBMCs at the time of entry into the study.
PatientHLA-AHLA-BHLA-DR
VC942124,2614,45NDa
LR3530183,11
KK81693,2435,51ND*
CZ84742449,6211,13
TS54371,2837,624,10
ER95193,2935,441,7
DG49651,2371,10
CC70621,2271,11
  • a ND, not determined. Inadequate number of lymphocytes available.